| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |